Shattuck Labs, Inc.
- STTK
- NASDAQ
- Biotechnology
- Immuno-Oncology
- Autoimmune Disease Therapies
$5.42
Today −1.99%Quote Oct 16, 2026, 08:00 PM UTC
−7.35%over the last month
Max drawdown −22.1%From 1-month high −20.8%3 months −20.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$544.0M
Quote Oct 16
Next earnings
Nov 10
Expected, not confirmed
Analyst target
$15.00
+176.8% from here
Floor
$5.31
2.0% below price
Where the price sits
9 analysts
Analyst range, low to high
$7.00$19.00
- Price $5.42
- Resistance $5.77–$5.83
- Consensus $15.00
Analysts' average target sits about 177% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about STTKPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
40